Quick Search

 

 


 

 

Result Summary for CAL.203

Result Summary
Protocol ID: CAL.203
Clinical Study ID: CAL.203
Official Title: A randomized, open-label study to assess the bioavailability of emulsion formulation calcipotriene foam, 0.005%, and dovonex® ointment, 0.005%, in patients with mild to moderate plaque-type psoriasis
Phase: phase 2
Study Indications or Diseases:
  • Psoriasis
Generic Name: calcipotriene
Trade/Product Name: Dovonex ointment
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.